Oncology

Close screening gaps before cancer finds them

Three of the most impactful HEDIS measures are cancer screenings: breast, colorectal, and cervical. For oncology practices that also manage survivorship, the stakes go further — surveillance protocols, recurrence screening, and the downstream care gaps that cancer patients accumulate while focused on treatment. Cancer also carries some of the highest-value HCC codes in the risk adjustment model.

Glance tracks screening compliance across your attributed population, monitors survivorship care gaps, and provides the financial analytics to demonstrate the value of early detection and coordinated cancer care in VBC contracts.

Schedule a Demo See Features
Glance — Cancer Screening
Screening Compliance — Attributed Population
Breast
78%
Colorectal
71%
Cervical
82%
Survivors
234
Screening Gaps
Mammography: 186 women overdue (ages 50-74)
Colonoscopy/FIT: 247 patients overdue (ages 45-75)
Cervical (Pap/HPV): 94 women overdue (ages 21-64)
Survivorship: 198 of 234 survivors with current surveillance

Cancer screening and survivorship analytics

Oncology in value-based care means closing screening gaps at scale and managing survivorship with the same rigor as active treatment.

Cancer Screening Compliance

Track breast cancer screening (mammography), colorectal cancer screening (colonoscopy, FIT, Cologuard), and cervical cancer screening (Pap/HPV co-testing) rates across your attributed population. Identify patients due or overdue for each screening. Generate outreach lists by screening type, age cohort, and risk level.

Survivorship Care Tracking

Cancer survivors need surveillance imaging, lab monitoring, and ongoing screening for secondary malignancies. Glance tracks survivorship protocols by cancer type and stage, flags overdue surveillance, and ensures that the care gaps survivors accumulate during treatment (missed mammograms, deferred colonoscopies, lapsed A1c testing) get closed in survivorship.

Oncology HCC Coding

Malignancies carry high-value HCC codes (HCC 8-12) that must be recaptured annually for active cancers and documented appropriately for remission/history. Glance surfaces patients with active cancer claims who may need recoding, patients transitioning from treatment to survivorship, and those with secondary conditions (anemia, malnutrition, pain) that carry additional HCCs.

Treatment Cost Analytics

Cancer treatment drives some of the highest per-patient costs in healthcare. Track total cost of care by cancer type, treatment phase (active vs. surveillance), and care setting. Benchmark against expected costs for each diagnosis to identify outliers and opportunities for value-based oncology contracting.

Population Health & Risk Stratification

Stratify your oncology population by active treatment vs. survivorship, by cancer stage, and by comorbidity burden. Identify which survivors are also managing diabetes, heart disease, or CKD — and ensure those conditions are not being neglected during or after cancer care.